The Role of Bone Health Agents in Patients with Prostate Cancer - Tia Higano

(Length of interview: 11 minutes)

Tia Higano and Alicia Morgans share their perspective on the data analysis from the ERA-223 phase III study and highlight the value of incorporating bone health management, weight-bearing and resistance exercise when treating patients with prostate cancer.


Celestia (Tia) S. Higano, MD, Director, Prostate Cancer Clinical Research Group, Seattle Cancer Care Alliance and a prostate cancer specialist and Professor of Medicine at the University of Washington School of Medicine and a member of Fred Hutchinson Cancer Research Center.   

Alicia Morgans, MD, MPH


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.